U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07362875) titled 'Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy' on Jan. 15.
Brief Summary: Myotonic dystrophy (dystrophia myotonica; DM), the most prevalent form of muscular dystrophy in adults, is characterized by progressive myopathy, myotonia, and multi-systemic involvement. DM causes severe disability and profoundly affects the patient's quality of life. Currently, no effective treatments are available that alter the course of the disease, but ongoing clinical trials are underway.
Study Start Date: May 15, 2025
Study Type: OBSERVATIONAL
Condition:
Myotonic Dystrophy
Recruitment Status: ...